These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4449022)

  • 21. Treatment of hypercholesterolaemia with colestipol: a bile sequestrating agent.
    Nye ER; Jackson D; Hunter JD
    N Z Med J; 1972 Jul; 76(482):12-6. PubMed ID: 4344110
    [No Abstract]   [Full Text] [Related]  

  • 22. Acceptability of cholestyramine or colestipol combinations with six vehicles.
    Shaefer MS; Jungnickel PW; Jacobs EW; Maloley PA
    Clin Pharm; 1987 Jan; 6(1):51-4. PubMed ID: 3816107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA; Heimann KW
    S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: In vitro binding of bile acids and bile salts.
    Kritchevsky D; Story JA
    Am J Clin Nutr; 1975 Apr; 28(4):305-6. PubMed ID: 1119427
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of anions on adsorption of bile salts by colestipol hydrochloride.
    Bilicki CV; White JL; Hem SL; Borin MT
    Pharm Res; 1989 Sep; 6(9):794-7. PubMed ID: 2813276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol lowering bile acid binding agents: novel lipophilic polyamines.
    Thomas EW; Cudahy MM; Spilman CH; Dinh DM; Watkins TL; Vidmar TJ
    J Med Chem; 1992 Apr; 35(7):1233-45. PubMed ID: 1560437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an unconventional in vitro drug release test method for a bile acid sequestrant, DMP 504, tablet.
    Wu LS; McCormick TJ; Chang RK; Pang J; McCummings T; Ramos M; Hussain MA
    Pharm Res; 1999 Jul; 16(7):1136-9. PubMed ID: 10450944
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of cholestyramine and colestipol on the absorption of hydrochlorothiazide.
    Hunninghake DB; King S; LaCroix K
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):151-4. PubMed ID: 7076343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia.
    Kinosian BP; Eisenberg JM
    JAMA; 1988 Apr; 259(15):2249-54. PubMed ID: 3127607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Choice of cholesterol-lowering drugs.
    Med Lett Drugs Ther; 1991 Jan; 33(835):1-4. PubMed ID: 1984601
    [No Abstract]   [Full Text] [Related]  

  • 31. Anion-exchange resins in pseudomembranous colitis.
    George RH; Youngs DJ; Johnson EM; Burdon DW
    Lancet; 1978 Sep; 2(8090):624. PubMed ID: 80541
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of cholestyramine and colestipol on the plasma concentrations of propranolol.
    Hibbard DM; Peters JR; Hunninghake DB
    Br J Clin Pharmacol; 1984 Sep; 18(3):337-42. PubMed ID: 6487473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrinsic factor-mediated binding of cyanocobalamin to cholestyramine.
    Andersen KJ; Schjønsby H
    J Pharm Sci; 1978 Nov; 67(11):1626-7. PubMed ID: 30840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choice of cholesterol-lowering drugs.
    Med Lett Drugs Ther; 1993 Mar; 35(891):19-22. PubMed ID: 8433674
    [No Abstract]   [Full Text] [Related]  

  • 35. Colestipol and clofibrate in hypercholesterolemia.
    Dujovne CA; Hurwitz A; Kauffman RE; Azarnoff DL
    Clin Pharmacol Ther; 1974 Aug; 16(2):291-6. PubMed ID: 4604239
    [No Abstract]   [Full Text] [Related]  

  • 36. The acceptability of resin therapy to patients attending a hospital lipid clinic.
    Iversen SA; Davidson D; Davidson C
    Br J Clin Pharmacol; 1995 Jul; 40(1):92-4. PubMed ID: 8527276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of colestipol and cholestyramine on the systemic clearance of intravenous ibuprofen in rabbits.
    el-Sayed YM; al-Meshal MA; al-Angary AA; Lutfi KM; Gouda MW
    J Pharm Pharmacol; 1994 Jan; 46(1):73-5. PubMed ID: 8201531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.
    Crouse JR
    Am J Med; 1987 Aug; 83(2):243-8. PubMed ID: 3618626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia.
    Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
    Drugs; 1980 Mar; 19(3):161-80. PubMed ID: 6988203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of cholestyramine and colestipol on the absorption of diclofenac in man.
    al-Balla SR; el-Sayed YM; al-Meshal MA; Gouda MW
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):441-5. PubMed ID: 7981930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.